The findings of this study together with those of other studies[2,13,28] propose that the +1858C/T PTPN22 SNP predisposes individuals to autoimmune diseases because of enhanced suppression of T-cell receptor signaling during thymic development, which allows the survival of auto-reactive T-cells. This evidence concerns the gene PTPN22 and autoimmune disease.